Direct Answer
Acetyl hexapeptide-8 (Argireline) is a synthetic peptide used in cosmetics and marketed for the appearance of expression lines. Ex vivo studies indicate limited skin penetration, and the cited human improvement was reported using a microneedle patch combined with other actives rather than topical application alone.
Summary Table
Evidence Level
High
Key Information
Classification
Key Takeaways
- Acetyl hexapeptide-8 (Argireline) is a cosmetic peptide marketed for expression-line appearance
- Ex vivo studies show limited topical skin penetration
- The cited human improvement used microneedle delivery plus other actives, not topical Argireline alone
Scientific Overview
In Plain English
Acetyl hexapeptide-8, known as Argireline, is a peptide used in anti-aging cosmetics aimed at the look of expression lines. Lab studies show it mostly stays in the outer skin layer when applied topically. The human study that reported smoother-looking skin used a microneedle patch combined with other ingredients, so the effect cannot be credited to topical Argireline by itself.
Scientific Details
Acetyl hexapeptide-8 is an acetylated hexapeptide studied as a cosmetic ingredient. An ex vivo skin-penetration study found it remained mostly in the stratum corneum, with only about 0.01% reaching the epidermis and none detected in the dermis. A double-blind, randomized, split-face human study reported improvements in the appearance of wrinkles and skin hydration, but it used a hyaluronic-acid microneedle patch combined with epidermal growth factor, so the effect cannot be attributed to acetyl hexapeptide-8 or to topical application alone.
How It Works
Acetyl hexapeptide-8 is described as a peptide marketed in relation to facial-expression-line appearance; in an ex vivo model topical penetration was limited to the outer skin layer, and the cited clinical improvement used microneedle delivery combined with other actives.
Mechanism of Action
Expression-line appearance
human
Marketed in relation to the appearance of expression lines; the cited human improvement used microneedle delivery combined with other actives, and ex vivo topical penetration was limited.
Evidence Level
Human Evidence
A double-blind, randomized, split-face study reported improvements in wrinkle appearance and hydration, delivered via a microneedle patch combined with epidermal growth factor.
Cell Evidence
An ex vivo skin study found topical penetration limited mainly to the stratum corneum.
Limitations
Topical penetration appears limited; the cited human benefit used microneedle delivery and a combined formulation, so it cannot be attributed to topical acetyl hexapeptide-8 alone.
References
- In vitro skin penetration of acetyl hexapeptide-8 from a cosmetic formulation. Cutaneous and Ocular Toxicology.Cell / In Vitrodoi:10.3109/15569527.2014.894521 →
- Anti-Wrinkle Efficacy of Cross-Linked Hyaluronic Acid-Based Microneedle Patch with Acetyl Hexapeptide-8 and Epidermal Growth Factor on Korean Skin. Annals of Dermatology.Human Studydoi:10.5021/ad.2019.31.3.263 →
Alternative Names
- Argireline
- Acetyl hexapeptide-3
- hexapeptide-8
Claim Boundaries
ION BLUE is an educational research aggregator. This content summarizes published scientific literature. It is not medically reviewed, is not medical advice, and is not a recommendation to use any substance. Several peptides discussed are research chemicals not approved for human use. Consult a licensed healthcare provider. Cited human benefit involved microneedle delivery and a combined formulation; this entry does not assert topical-Argireline-alone benefits and is not a recommendation to use it.
This page summarizes published research and is for informational purposes only; it is not medical advice.